دورية أكاديمية

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)

التفاصيل البيبلوغرافية
العنوان: Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)
المؤلفون: De Grève, Jacques, Van Meerbeeck, Jan, Vansteenkiste, Johan F., Decoster, Lore, Meert, Anne-Pascale, Vuylsteke, Peter, Focan, Christian, Canon, Jean-Luc, Humblet, Yves, Berchem, Guy, Colinet, Benoit, Galdermans, Danny, Bosquée, Lionel, Vermeij, Joanna, Dewaele, Alex, Geers, Caroline, Schallier, Denis, Teugels, Erik
المساهمون: Rosell, Rafael
المصدر: PLOS ONE ; volume 11, issue 3, page e0147599 ; ISSN 1932-6203
بيانات النشر: Public Library of Science (PLoS)
سنة النشر: 2016
المجموعة: PLOS Publications (via CrossRef)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1371/journal.pone.0147599
الإتاحة: https://doi.org/10.1371/journal.pone.0147599Test
حقوق: http://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.4FC69BFE
قاعدة البيانات: BASE